The most commonly occurring adverse drug reactions and the most frequently reported serious adverse drug reactions during post-marketing surveillance are Anaphylaxis, Prolonged neuromuscular block, Myopathy, Local injection site reactions and Pain near the site of injection, Tachycardia, The drug is not effective enough, The drug works for longer than expected, Lowering of blood pressure.